Interest of the Automated Management of Deep Neuromuscular Blockade Monitoring (CURATP) - Trial NCT05784610
Access comprehensive clinical trial information for NCT05784610 through Pure Global AI's free database. This phase not specified trial is sponsored by Poitiers University Hospital and is currently Enrolling by invitation. The study focuses on Neuromuscular Blockade. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Poitiers University Hospital
Timeline & Enrollment
N/A
Nov 01, 2022
May 01, 2023
Primary Outcome
Evaluate the monitoring of deep NMB by automated management of the measurement of depth NMB (ATP mode) compared to non-automated monitoring (PTC/TOF) in order to improve the maintenance of deep NMB during abdominal surgery
Summary
Neuromuscular blockade (NMB) recommendations updated in 2018 by the Société Française
 d'Anesthésie et Réanimation (SFAR) recommend the use of NMB agents to facilitate surgical
 procedure during abdominal surgery by laparotomy or laparoscopy.
 
 This study aims to evaluate deep NMB monitoring with automated management of NMB depth
 measurement (ATP mode) versus non-automated monitoring (PTC/TOF), in order to improve the
 maintenance of deep NMB during abdominal surgery.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05784610
Device Trial